Boston Scientific CorporationBSXNYSE
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year gross profit growth rate
Latest
3.45%
Near historical average
Average (39q)
3.21%
Historical baseline
Range
High:59.37%
Low:-34.77%
CAGR
-0.5%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 3.45% |
| Q2 2025 | 16.07% |
| Q1 2025 | 10.45% |
| Q4 2024 | 0.87% |
| Q3 2024 | 2.44% |
| Q2 2024 | 8.43% |
| Q1 2024 | 3.11% |
| Q4 2023 | 6.69% |
| Q3 2023 | -4.79% |
| Q2 2023 | 9.58% |
| Q1 2023 | 6.24% |
| Q4 2022 | 1.40% |
| Q3 2022 | -3.02% |
| Q2 2022 | 7.87% |
| Q1 2022 | -5.05% |
| Q4 2021 | 5.95% |
| Q3 2021 | -5.66% |
| Q2 2021 | 16.50% |
| Q1 2021 | 11.06% |
| Q4 2020 | -4.58% |
| Q3 2020 | 59.37% |
| Q2 2020 | -34.77% |
| Q1 2020 | -17.19% |
| Q4 2019 | 5.61% |
| Q3 2019 | 2.00% |
| Q2 2019 | 6.40% |
| Q1 2019 | -4.89% |
| Q4 2018 | 5.74% |
| Q3 2018 | -2.76% |
| Q2 2018 | 2.64% |
| Q1 2018 | -1.24% |
| Q4 2017 | 11.43% |
| Q3 2017 | -1.70% |
| Q2 2017 | 8.18% |
| Q1 2017 | -5.17% |
| Q4 2016 | 5.07% |
| Q3 2016 | -7.16% |
| Q2 2016 | 6.92% |
| Q1 2016 | -1.15% |
| Q4 2015 | 4.20% |